February New Deal Reads
Oral nanoparticles of SNX10-shRNA plasmids ameliorate Mouse Colitis. W.Bao, Q.Wu, [...]
January New Deal Reads
Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle [...]
IBD & Tea: what patients want to know when it comes to a clinical trial
Often, patients who live with Inflammatory Bowel Disease (IBD) do [...]
November New Deal Reads
Patient involvement in clinical research: why, when and how. Sacristán [...]
IBD & Tea: Building trust in new treatments & understanding clinical trials
Tina Aswani Omprakash is an award-winning blogger, speaker and patient [...]
Small drugs – Big considerations: How New Deal researchers are overcoming the challenges of scaling-up a potential IBD nanomedicine
A great chef could create an outstanding dish that revolutionizes [...]
October New Deal Reads
Extracellular Vesicles With Possible Roles in Gut Intestinal Tract Homeostasis [...]
From the lab to the market: regulations and development of new treatments.
Translating research ideas into prescription medicines is a long journey [...]
September New Deal Reads
Molecular Structure and Function of Janus Kinases: Implications for the [...]
COVID-19 and Inflammatory Bowel Disease: an insight into the relationship between conditions
In December 2019 the now named severe acute respiratory syndrome [...]
